Literature DB >> 34810182

Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence.

Genevieve Cezard1, Calum Thomas McHale2, Frank Sullivan2, Juliana Kuster Filipe Bowles3, Katherine Keenan4.   

Abstract

OBJECTIVES: Multimorbidity-the co-occurrence of at least two chronic diseases in an individual-is an important public health challenge in ageing societies. The vast majority of multimorbidity research takes a cross-sectional approach, but longitudinal approaches to understanding multimorbidity are an emerging research area, being encouraged by multiple funders. To support development in this research area, the aim of this study is to scope the methodological approaches and substantive findings of studies that have investigated longitudinal multimorbidity trajectories.
DESIGN: We conducted a systematic search for relevant studies in four online databases (Medline, Scopus, Web of Science and Embase) in May 2020 using predefined search terms and inclusion and exclusion criteria. The search was complemented by searching reference lists of relevant papers. From the selected studies, we systematically extracted data on study methodology and findings and summarised them in a narrative synthesis.
RESULTS: We identified 35 studies investigating multimorbidity longitudinally, all published in the last decade, and predominantly in high-income countries from the Global North. Longitudinal approaches employed included constructing change variables, multilevel regression analysis (eg, growth curve modelling), longitudinal group-based methodologies (eg, latent class modelling), analysing disease transitions and visualisation techniques. Commonly identified risk factors for multimorbidity onset and progression were older age, higher socioeconomic and area-level deprivation, overweight and poorer health behaviours.
CONCLUSION: The nascent research area employs a diverse range of longitudinal approaches that characterise accumulation and disease combinations and to a lesser extent disease sequencing and progression. Gaps include understanding the long-term, life course determinants of different multimorbidity trajectories, and doing so across diverse populations, including those from low-income and middle-income countries. This can provide a detailed picture of morbidity development, with important implications from a clinical and intervention perspective. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  epidemiology; internal medicine; preventive medicine; public health; statistics & research methods

Mesh:

Year:  2021        PMID: 34810182      PMCID: PMC8609933          DOI: 10.1136/bmjopen-2020-048485

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   3.006


  65 in total

1.  Single data extraction generated more errors than double data extraction in systematic reviews.

Authors:  Nina Buscemi; Lisa Hartling; Ben Vandermeer; Lisa Tjosvold; Terry P Klassen
Journal:  J Clin Epidemiol       Date:  2006-03-15       Impact factor: 6.437

2.  Association between nutrition and the evolution of multimorbidity: the importance of fruits and vegetables and whole grain products.

Authors:  Guillaume Ruel; Zumin Shi; Shiqi Zhen; Hui Zuo; Edeltraut Kröger; Caroline Sirois; Jean-Frédéric Lévesque; Anne W Taylor
Journal:  Clin Nutr       Date:  2013-07-22       Impact factor: 7.324

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Diagnosis trajectories of prior multi-morbidity predict sepsis mortality.

Authors:  Mette K Beck; Anders Boeck Jensen; Annelaura Bach Nielsen; Anders Perner; Pope L Moseley; Søren Brunak
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

5.  Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India.

Authors:  Sanghamitra Pati; Subhashisa Swain; Job Metsemakers; J André Knottnerus; Marjan van den Akker
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

6.  Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice.

Authors:  Lucy E Stirland; Laura González-Saavedra; Donncha S Mullin; Craig W Ritchie; Graciela Muniz-Terrera; Tom C Russ
Journal:  BMJ       Date:  2020-02-18

7.  Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults.

Authors:  Laura M Pérez; Babak Hooshmand; Francesca Mangialasche; Patrizia Mecocci; A David Smith; Helga Refsum; Marco Inzitari; Laura Fratiglioni; Debora Rizzuto; Amaia Calderón-Larrañaga
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

8.  Defining and measuring multimorbidity: a systematic review of systematic reviews.

Authors:  Marjorie C Johnston; Michael Crilly; Corri Black; Gordon J Prescott; Stewart W Mercer
Journal:  Eur J Public Health       Date:  2019-02-01       Impact factor: 3.367

9.  What Is the Impact of Physical Activity and Physical Function on the Development of Multimorbidity in Older Adults Over Time? A Population-Based Cohort Study.

Authors:  Aine Ryan; Catriona Murphy; Fiona Boland; Rose Galvin; Susan M Smith
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-10-08       Impact factor: 6.053

10.  Mining patterns of comorbidity evolution in patients with multiple chronic conditions using unsupervised multi-level temporal Bayesian network.

Authors:  Syed Hasib Akhter Faruqui; Adel Alaeddini; Carlos A Jaramillo; Jennifer S Potter; Mary Jo Pugh
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

View more
  7 in total

Review 1.  Multimorbidity.

Authors:  Søren T Skou; Frances S Mair; Martin Fortin; Bruce Guthrie; Bruno P Nunes; J Jaime Miranda; Cynthia M Boyd; Sanghamitra Pati; Sally Mtenga; Susan M Smith
Journal:  Nat Rev Dis Primers       Date:  2022-07-14       Impact factor: 65.038

2.  Understanding multimorbidity trajectories in Scotland using sequence analysis.

Authors:  G Cezard; F Sullivan; K Keenan
Journal:  Sci Rep       Date:  2022-10-01       Impact factor: 4.996

3.  Does group-based trajectory modeling estimate spurious trajectories?

Authors:  Miceline Mésidor; Marie-Claude Rousseau; Jennifer O'Loughlin; Marie-Pierre Sylvestre
Journal:  BMC Med Res Methodol       Date:  2022-07-14       Impact factor: 4.612

Review 4.  Multimorbidity matters in low and middle-income countries.

Authors:  Ana Basto-Abreu; Tonatiuh Barrientos-Gutierrez; Alisha N Wade; Daniela Oliveira de Melo; Ana S Semeão de Souza; Bruno P Nunes; Arokiasamy Perianayagam; Maoyi Tian; Lijing L Yan; Arpita Ghosh; J Jaime Miranda
Journal:  J Multimorb Comorb       Date:  2022-06-16

5.  Life Course Digital Twins-Intelligent Monitoring for Early and Continuous Intervention and Prevention (LifeTIME): Proposal for a Retrospective Cohort Study.

Authors:  Madison Milne-Ives; Lorna K Fraser; Asiya Khan; David Walker; Michelle Helena van Velthoven; Jon May; Ingrid Wolfe; Tracey Harding; Edward Meinert
Journal:  JMIR Res Protoc       Date:  2022-05-26

6.  Multimorbidity and mortality: A data science perspective.

Authors:  Kien Wei Siah; Chi Heem Wong; Jerry Gupta; Andrew W Lo
Journal:  J Multimorb Comorb       Date:  2022-06-01

7.  Physical Activity as a Mediator Between Race/Ethnicity and Changes in Multimorbidity.

Authors:  Jason T Newsom; Emily C Denning; Miriam R Elman; Anda Botoseneanu; Heather G Allore; Corey L Nagel; David A Dorr; Ana R Quiñones
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-08-11       Impact factor: 4.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.